本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Regenxbio Inc

9.22
+0.29003.25%
成交量:24.20万
成交额:223.43万
市值:4.66亿
市盈率:-2.69
高:9.43
开:8.75
低:8.75
收:8.93
52周最高:13.48
52周最低:5.04
股本:5,051.42万
流通股本:4,142.31万
量比:0.50
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):-3.4333
每股收益(LYR):-4.5871
净资产收益率:-62.49%
总资产收益率:-17.88%
市净率:2.18
市盈率(LYR):-2.01

数据加载中...

2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/06

重要事件披露

Form 8-K - Current report
2023/05/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/05/03

重要事件披露

8-K - Current report
2023/05/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]